1. Home
  2. PDEX vs PRQR Comparison

PDEX vs PRQR Comparison

Compare PDEX & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pro-Dex Inc.

PDEX

Pro-Dex Inc.

HOLD

Current Price

$61.33

Market Cap

189.2M

Sector

Health Care

ML Signal

HOLD

Logo ProQR Therapeutics N.V.

PRQR

ProQR Therapeutics N.V.

HOLD

Current Price

$1.81

Market Cap

166.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PDEX
PRQR
Founded
1978
2012
Country
United States
Netherlands
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
189.2M
166.5M
IPO Year
1995
2014

Fundamental Metrics

Financial Performance
Metric
PDEX
PRQR
Price
$61.33
$1.81
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
4
Target Price
$56.00
$7.25
AVG Volume (30 Days)
55.9K
1.2M
Earning Date
05-01-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
345.00
N/A
EPS
3.27
N/A
Revenue
$66,593,000.00
N/A
Revenue This Year
$7.22
N/A
Revenue Next Year
N/A
$13.92
P/E Ratio
$19.19
N/A
Revenue Growth
23.68
N/A
52 Week Low
$23.52
$1.33
52 Week High
$68.99
$3.10

Technical Indicators

Market Signals
Indicator
PDEX
PRQR
Relative Strength Index (RSI) 50.44 56.15
Support Level $59.06 $1.39
Resistance Level $68.99 $2.05
Average True Range (ATR) 4.17 0.19
MACD -0.53 0.02
Stochastic Oscillator 55.76 70.63

Price Performance

Historical Comparison
PDEX
PRQR

About PDEX Pro-Dex Inc.

Pro-Dex Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers (OEMs) to various countries. Its product portfolio includes autoclavable, battery-powered, electric, and multi-function surgical drivers and shavers used mainly in orthopedic, thoracic, and craniomaxillofacial markets. The company also provides engineering, quality, regulatory consulting services, and manufactures rotary air motors utilized in various industries. Operating out of ISO-certified facilities in California, Pro-Dex serves hospitals, medical labs, and high-tech manufacturers, generating revenue through sales of surgical instruments and related services.

About PRQR ProQR Therapeutics N.V.

ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics. Geographically, the company operates in United States.

Share on Social Networks: